Business Status

Growth support

Growth support

 

Discover our bio-specialized incubation and acceleration programs,

engaging seminars and conferences, technology exchange programs,

 and personalized 1:1 mentoring with experts in management, investment, IP, and beyond.

Business Expansion
  • Overseas market analysis and export initiative consulting leveraging a in-depth understanding of foreign markets.
  • Connection with global pharma leaders to strengthen the pipeline for sustained success in product development and commercialization.
  • Leveraging established company's infrastructure and network for time and cost efficiency.
  • Strategic planning for collaborative initiatives and mutual success.
Facilitate the development of the master plan for R&D strategy.
  • Access to a global pipeline by collaborating with prominent investment firms that have invested in international bio-companies.
  • Provide foundation and strategic launchpad for growth and international expansion through open innovation.
Connect to global biopharma community through international conferences.
  • Explore diverse organizations and connect with potential buyers at international conferences.
  • Secure opportunities to participate in conferences and exhibitions through government-sponsored programs.
Leverage government-supported programs to establish a foundation for global expansion.
TIPS
  • we were selected for the National Certified Tech Incubator Program for startups, TIPs.
  • Discover and invest in bio·healthcare venture companies

Collaborative bio-accelerating consortium 
for growth support

좌우스크롤 이미지After clicking the screen, please scroll down or move the screen left/right.

Specialized bio-accelerating consortium for startups

Hardware infrastructure provider for
R&D (WOOJUNGBIO).
15F
Consulting Space(IP, IR, investment, etc.)
13F
Consortium Group Office
11-12F
Corporate Offices
8-10F
LAB CLOUD Members
5-7F
Corporate Offices & Cell Culture Lab
4F
Analysis Research Center
3F
Conference hall, Education and Meeting rooms
2F
Cafeteria, Dining Area, and Meeting room
B4-5
Vivarium Research Center
Software support providers (WOOJUNGBIO consortium & partners)
Investment network
deal-sourcing, follow-up investments,
domestic and international VCs
Public agencies and associations
Connection to policy-based initiatives
Public tech development and joint research program.
Field experts consulting
In-house and external expertise in tech management, marketing, legal, investments, etc.
LAB CLOUD Acceleration Goals
Category 2023 2025 2027
Company identification and incubation(cumulative) 30 client companies 100 client companies 200 client companies
Investment Execution 20 B KRW, 100B KRW (including funds) 300B KRW (including funds))
Number of Invested Companies. 10 resident companies 20 resident companies 30 resident companies
LAB CLOUD Operation
01
Strategic partner
for R&D
02
Bio-specialized
acceleration program
03
Maximizing tech valuation for commercialization

Bio-acceleration program:
A systematic and customized growth support
for stage-specific needs.

Incubating

Optimal environment to streamline resources into research

Shared lab space
Immediate access to fully equipped research facilities and equipment upon joining
Exclusive office space
Space provision for necessary operational activities
Training support
Regular education and training sessions for new drug development experts and investment mentoring
Networking Platform
Access to consortium of professionals with common interests in R&D, legal or investment.
Accelerating

Systematic and comprehensive growth support at each stage

Tech Transaction Consultation
Consult on license-in and -out, M&A, and tech transaction
Tailored marketing strategy
Investment attraction support.
Intellectual Property (IP) legal management
Identifying promising technologies and securing patents, portfolio management, strategic planning and customized technology consulting.

Systematic growth support from a bio-accelerating consortium, fostering collaboration across all relevant fields.

01.
IP Analaysis / IP-driven R&D
Intellectual Property(IP) analysis to identify and assess infringement issues of owned technology, both domestically and internationally, and evaluating confirmation and avoidance possibilities.
02.
Master plan for R&D strategy.
  • Research Stage: Comprehensive early-stage consultation for new drug development, beginning with pharmaceutical product classification.
  • Development Stage: Gap analysis, IND-enabling non-clinical design, CMC (chemistry, manufacturing, and controls), and clinical development pre-advisory consulting.
  • Pre-IND Stage: Clinical development consultation for target indication.
03.
Pharmaco-toxicology analysis & consulting
Enhance R&D efficiency by anticipating potential toxicity of new candidate substances, reducing trial and error.
04.
CMC pre-consulting
Stage-specific CMC (Chemistry, manufacturing, and control) consulting by modalities (chemical, cell-therapy, etc.)
05.
Non-clinical consulting
Support in developing non-clinical design (efficacy/toxicity testing) for clinical trials.
06.
Licence-in BD
Regulatory Approval BD consultation for KFDA/FDA/EMA applications with necessary documents, procedural guidance, and additional assistance.
07.
License-out BD
License-out strategy and valuation consulting based on market, pricing (e.g., insurance coverage), positioning, and competitive landscape analysis.
08.
Mentoring
Customized mentoring to address stage-specific challenges through industry experts.

Targeted Public Relations for startups with a multi-channel communication approach.

Verified
promotional  channels

Bio-specialized
organizations

Blogs

SNS, Youtube

Press
Newsletters

Investment institutions.

Website
  • Monthly average of 3,000 visits and 12,000 page views
  • Approx. 100 daily visits
Press outlets

Coverage from 75 press outlets, pool of approx. 170 reporters

Affiliated organizations

Connections with 16 relevant affiliated institutions.

SNS Channels
  • 576 Facebook followers, 242 KakaoTalk friends
  • 120 YouTube subscribers with 264 average views
  • Newsletter open rate around 20%
Promotional support for resident companies

Promotion agency services through in-house multi-channels for supplementary needs

Open Innovation Platform- private-public collaboration

*Government
Ministry of SMEs and Startups, Korea Institute of Startup & Entrepreneurship Development, Korea Health Industry Development Institute, Business and Employment Agencies / Local Governments (Gyeonggi Province, Busan Metropolitan City, Incheon Metropolitan City, Hwaseong City, etc.) / Regional Affiliated Organizations (Special Economic Zones, Techn Parks, Innovation Centers, KOTRA, Chambers of Commerce, etc.)
**Associations
Pharmaceutical and Biotech Associations, Pharmaceutical Development Research Alliance, Korean Early-Stage Investment Association, Korean Physician Entrepreneurship Research Society, Digital Healthcare Forum, etc.
21.4B KRW

LAB CLOUD Investment Performance with 10 cases of direct/indirect investments

112

LAB CLOUD consortium partner companies

20

LAB CLOUD bio-startup members

63+

accelerating
programs

106.7B KRW
LAB CLOUD Members' Investment Attraction

11.7B KRW

 
SEED

40B KRW

 
Series A

55B KRW

 
Series B

Collaborative platform with Government, Agencies, and Associations to provide support for R&D and business operations.

Addressing the biotech sector's collaborative needs, we offer tailored solutions through collective research and development, fostering joint technological advancement with diverse institutions and companies.

좌우스크롤 이미지After clicking the screen, please scroll down or move the screen left/right.

Supervision Program name Details
Public-private collaborative open innovation platform With 'private sector-led & gov. supported' approach, WOOJUNGBIO identifies promising startups and support their tech advancement and commercialization in collaboration with the government.
BRIDGE TO KOREA Joint acceleration for bio startups (commercialization, global expansion, R&D advancement, etc.)
Connection to private investment Technology Startups Center Support startups through private-sector-led investment and comprehensive programs—education, mentoring, space provision, IR pitching, follow-up funding—with government backing.
Subcommittee for supporting SMEs Offer precise growth strategies by addressing challenges faced by local bio enterprises (startups, chemistry, biotech, and medical fields).
Global 1000+ Provide stage-specific vouchers as part of an integrated export support program to offer tailored assistance in various export marketing aspects.
Collaboration with large and medium-sized enterprises
Open innovation		 Financial support for startups' swift market entry and sustainable business growth
I’M Challenge Facilitating partnerships between startups and large/medium-sized enterprises to provide access to open innovation opportunities and comprehensive support for sustained growth.
Search Close